[{"title": "Ibrutinib Increases Phosphorylation of the Src-Erk1/2 Signaling Pathway in Human Atrial-Specific Cardiomyocytes Derived from Induced Pluripotent Stem Cells", "link": "https://www.ahajournals.org/doi/abs/10.1161/circ.150.suppl_1.4139038", "details": "M Fleming, M O'Neill, T Yang, J Solus, B Kroncke\u2026 - Circulation, 2024", "abstract": "Background: The Bruton's tyrosine kinase (BTK) inhibitor ibrutinib has revolutionized treatment for B-cell malignancies but increases the incidence of atrial fibrillation (AF) compared with conventional chemotherapy. Reports indicate that ibrutinib-mediated \u2026"}, {"title": "Chimpanzee Induced Pluripotent Stem Cells (iPSCs)-derived Cardiomyocytes as Surrogates for Human iPSCs in Cardiomyocyte Research and Cross-Species \u2026", "link": "https://www.ahajournals.org/doi/abs/10.1161/circ.150.suppl_1.4140565", "details": "M Roodgar, M Parham, F Suchi, V Bajpai, H Nakauchi\u2026 - Circulation, 2024", "abstract": "Induced pluripotent stem cells (iPSCs) provide valuable insights into early tissue and organ development, with potential applications in cross-species comparative studies. Nonhuman primate (NHP) iPSCs, particularly those derived from chimpanzees (Pan \u2026"}]
